期刊文献+

CpG-ODN加强树突状细胞疫苗治疗小鼠膀胱肿瘤的实验研究 被引量:1

Study on enhancement of DC vaccine to murine bladder carcinoma by CpG oligodeoxynucleotide
下载PDF
导出
摘要 目的探讨含CpG序列的寡脱氧核糖核苷酸(CpG-ODN)对树突状细胞(DC)疫苗治疗小鼠膀胱肿瘤作用的影响。方法应用CpG-ODN作为DC成熟的刺激信号,体外诱导DC成熟,BTT739膀胱肿瘤细胞抗原提取物致敏DC制备DC疫苗,建立BTT739荷瘤小鼠动物模型,随机分为磷盐酸缓冲液(PBS)对照组、DC疫苗组、CpG-ODN组、DC+CpG-ODN联合治疗组,于肿瘤细胞接种后第7、14天给予治疗,每组分2个亚组,分别用于测量瘤重、体积及用于观察荷瘤小鼠存活情况。流式细胞仪检测肿瘤组织中浸润性树突状细胞(TIDC)表面共刺激分子CD80、CD86的表达。结果第2次治疗7 d后,联合治疗组平均瘤重及平均肿瘤体积均显著低于其余3个组(P<0.01),荷瘤小鼠生存期显著长于其余3个组(P<0.05)。肿瘤组织中TIDC表面CD80、CD86表达水平,联合治疗组略高于CpG-ODN组,差异无统计学意义(P>0.05),但均显著高于PBS对照组和DC疫苗组(P<0.05)。结论CpG-ODN可增强负载肿瘤抗原的DC疫苗对膀胱肿瘤荷瘤小鼠的抑瘤效应和生存期延长作用,其机制主要是通过诱导DC成熟。 Objective To investigate whether CpG oligodeoxynucleotide (CpG-ODN) can affect the immunotherapeutic effects of DC vaccine on murine bladder carcinoma. Methods CpG-ODN was used to promote maturation of DCs in vitro. DCs were plused with BTT739 cell antigen and I)C vaccine was prepared. After the BTT739 bladder tumor model in 48 T739 mice were successfully established, phosphate buffered saline,DC vaccine, CpG-ODN and DC--CpG-ODN were injected respectively into the margins of the tumor(peritumoral) on 7 d and 14 d after tumor cells inoculation. Tumor weight,volume and the life span of mice were recorded. The expression levels of CD80 and CD86 on TIDC of tumor tissues were detected by flow cytometry. Results On 7 d after the sec- ond injection,average tumor weight and average tumor volume in DC+CpG-ODN group was lower than those in control group,DC group and CpG-ODN group(P^0.01). The life span of mice in DC+CpG-ODN group was significantly longer than that in the oth er three groups(P^0.05). The expression levels of CD80 and CD86 on TIDC in DC^CpG-()DN group and CpG OI)N group were higher than that in control group and DC group(P^O. 05). Conclusion CpG-ODN can enhance the immunolherapeutic effects of DC vaccine on inhibiting tumor growth and prolonging the living time of T739 mice with BTT739 bladder lumor via inducing the maturation of DC.
出处 《重庆医学》 CAS CSCD 北大核心 2010年第6期648-650,共3页 Chongqing medicine
关键词 寡脱氧核糖核苷酸 膀胱肿瘤 树突状细胞 疫苗 oligodeoxynucleotide bladder carcinoma dendritic cell vaccine
  • 相关文献

参考文献9

  • 1Pilon TS, i.i W, Briggs JJ, et al. Immunostimulatory effects of CpG-ODN upon dendritic cell-based immunotherapy in a murine melanoma model[J]. J Immunother, 2006,29(4) :381.
  • 2聂志林,靳风烁,梁培禾,叶锦.CpG-ODN促进小鼠骨髓来源的树突状细胞成熟作用的实验研究[J].重庆医学,2008,37(2):136-138. 被引量:2
  • 3Actins H,Davis BR,Kirby JA,et al. Polarisation of a Thelper cell immune response by activation of dendritic cells with CpG-containing oligonucleotides: a potentiao therapeutic regime: for bladder cancer immunotherapy[J]. Br J Cancer,2003,89(12) :2312.
  • 4高维实,闵军,褚忠华,陈涛,魏菁,区庆嘉.肝癌细胞冻融抗原负载树突状细胞瘤苗的制备与活化[J].中国病理生理杂志,2003,19(9):1279-1282. 被引量:7
  • 5Silke G, Michael S, Herbert R. Dendritic cells pulsed with tumor-derived lysate augment T cell mediated tumor cell lysis[J]. Otolaryngol Head Neck Surg, 2004, 131 (2): 176.
  • 6Baines J, Celis E. Immune-mediated tumor regression induced by CpG-containing oligodeoxynucleotides [J]. Clin Cancer Res,2003,9(7) :2693.
  • 7Heckelsmiller K, Rail K, Beck S, el al. Peritumoral CpG DNA elicits a coordinated response of CD8 T cells and innate effectors to cure established tumors in a murine colon carcinoma model[J]. J Immunol,2002,169(7) :3892.
  • 8Heckelsmiller K, Beck S, Rail K, et al. Combined dendritic cell- and CpG oligonucleotide-based immune therapy cures large murine tumors that resist chemotherapy[J]. Eur J Immunol, 2002,32 : 3235.
  • 9杜宇琛,林苹,张洁,陆燕蓉,宁其志.CpG ODN加强树突状细胞疫苗抗Lewis肺癌的研究[J].中华肿瘤杂志,2005,27(1):1-5. 被引量:8

二级参考文献27

  • 1Lanzavecchia A, SaUusto F. Regulation of T cell immunity by dendritic cells[J]. Cell, 2001,106(3) :263 - 266.
  • 2Morse MA, Mosca PJ, Clay TM, et al. Dendritic cell maturation in active immunotherapy strategies[J]. Expert Opin Biol Ther, 2002, 2( 1 ) : 35 - 43.
  • 3Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte macrophage colony - stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha[J]. J Exp Med, 1994,179(4) : 1109 - 1118.
  • 4Morse MA, Zhou I j, Tedder TF, et al. Generation of dendritic cells in vitro from peripheral blood mononuclear cells with granulocyte- macmphage- colony- stimulating factor, interleukin - 4, and tumor necrosis factor- alpha for use in cancer immunotherapy[J]. Ann Surg,1997, 226(1):6- 16.
  • 5Bachleitner- Hofmann T, Stift A, Friedl J, et al. Stimulation of autologous anfitumor T- cell responses against medullary thyroid carcinoma using tumor lysate- pulsed dendritic cells[J]. J Clin Endocrinol Metab, 2002, 87(3):1098- 1104.
  • 6Schnurr M, Galambos P, Scholz C, et al. Tumor cell lysate-pulsed human dendritic cells induce a T- cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines[J]. Cancer Res, 2001 ,61(17):6445-6450.
  • 7Kanto T, Hayashi N, Takehara T, et al. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus - infected individuals [ J ]. J Immunol,1999, 162(9) :5584- 5591.
  • 8Mellman I, Steitunan R. Dendritic cells: specialized and regulated antigen processing machine. J Cell, 2001, 106: 255-258.
  • 9Chiodoni C, Paglia P, Stoppacciaro A, et al. Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor( GM-CSF)and CIMO ligand genes take up and present endugenuus tumor-associated antigens, and prim naive mice for a cytotoxic T lymphocyte response. J Exp Med, 1999, 190: 125-133.
  • 10Dallal R, Christakos P, kee K, et al. Paucity of dendritic cells in pancreatic cancer. Surgery, 2002, 131: 135-138.

共引文献13

同被引文献43

  • 1金璐,赵玉伟,李知勉,赵成建,王晓飞,张凌,杨寒朔.真核表达人和鼠可溶性VEGFR2的双基因疫苗的构建及抗肿瘤实验研究[J].四川大学学报(医学版),2010,41(4):563-566. 被引量:3
  • 2和祯泉,刘天健,吕英军,鲍恩东.抗菌肽Folicidin-3在大肠杆菌中融合表达及抑菌活性[J].扬州大学学报(农业与生命科学版),2011,32(4):1-6. 被引量:6
  • 3陈曦,孙国军,赵文静,焦健,刘松涛,梁冰,刘双燕.自体骨髓干细胞治疗终末期肝病24例临床观察[J].临床肝胆病杂志,2012,28(1):55-57. 被引量:6
  • 4吴梧桐.生化与生物技术药物的研发现状与发展方向[R].2012’中国生物药物创新研究论坛-酶类药物的研究与开发论文集.2012.
  • 5Huggett B, Hodgson J, Lhteenmki R. Public Biotech 2010- the numbers [ J]. Nature Biotechnology ,2011,29 :585.
  • 6邓洪民,张靖溥.2010年我国重组细胞因子药物研究进展[R].中国药学年鉴,2011,57.
  • 7李谦,王友同.2009年我国生物技术药物研究进展[R].中国药学年鉴,2010,43.
  • 8刘芳君,郝海峰,王冬梅,等.融合蛋白GST-hRI糖尿病性白内障模型大鼠晶状体浑浊程度的改善作用研究[J].中国药学,2011,22(5):395.
  • 9Zhou JJ, Chen ML, Zhang QZ. Blocking gastrin and CCK-B autoc- sine loop affects cell proliferation and apoptosis in vitro [ J ]. Mol Cell Biochem,2010,343 ( 1-2 ) : 133.
  • 10Pang JC, Li KK, Lau KM, et al. KIAA 0495/PDAM Is frequantly downregulated in oligodendroglial tumors and its Knockdown by siRNA iduces cisplatin resistance in Glioma Cell [ J ]. Brain Pathol,2010 ,20( 6 ) :1021.

引证文献1

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部